), an innovator and pioneer in developing products for the treatment of sleep-disordered breathing and respiratory conditions. The Food and Drug Administration (FDA) recently cleared ResMed's home ...
The American Thoracic Society (ATS) and Sunovion Pharmaceuticals Inc. (Sunovion) today announced the results of a survey of pulmonologists and pulmonology fellows to determine physicians’ knowledge, ...
Everyday Health on MSN
More energy, less breathlessness: 5 tips to preserve independence with COPD
Learn practical energy-conservation strategies and dietary adjustments to manage COPD symptoms, reduce shortness of breath, ...
Please provide your email address to receive an email when new articles are posted on . Available studies on wearable devices and COPD exacerbations have differing data collection methods. Patient ...
Cognitive impairment, manual dexterity, and suboptimal peak inspiratory flow are associated with inadequate inhaler technique and poor outcomes in patients with chronic obstructive pulmonary disease ...
The U.S. Chronic Obstructive Pulmonary Disease Market is projected to grow from USD 6.93 Billion in 2025 to USD 10.93 Billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results